Raymond James Financial
IBB icon

Raymond James Financial’s iShares Biotechnology ETF IBB Stock Holding History

Raymond James Financial’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$174M Buy
1,029,709
+35,398
+4% +$6.05M 0.05% 321
2025
Q4 		$168M Buy
994,311
+736,881
+286% +$120M 0.05% 321
2025
Q3 		$37.2M Sell
257,430
-2,311
-0.9% -$315K 0.01% 992
2025
Q2 		$32.9M Sell
259,741
-91,459
-26% -$11.2M 0.01% 1030
2025
Q1 		$44.9M Sell
351,200
-64,881
-16% -$8.8M 0.02% 777
2024
Q4 		$55M Buy
+416,081
New +$58.5M 0.02% 673

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial's IBB Position: Q1 2026 in Review

Raymond James Financial increased its iShares Biotechnology ETF (IBB) stake by 3.6% in Q1 2026, buying an estimated $6.05M and bringing the position to 1,029,709 shares worth $174M. The position accounts for 0.05% of the portfolio, ranked #321.

Raymond James Financial first reported a position in IBB in Q4 2024 and has held it in 6 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Raymond James Financial held 1,029,709 shares of iShares Biotechnology ETF worth $174M as of Q1 2026.
  • Raymond James Financial bought 35,398 iShares Biotechnology ETF shares in Q1 2026, an estimated $6.05M.
  • iShares Biotechnology ETF made up 0.05% of Raymond James Financial's portfolio in Q1 2026, its #321 holding.
  • Raymond James Financial first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.